PANNONE LOPES DEVEREAUX & O'GARA LLC

Lobbying for AMGEN · Biotechnology company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · $9,000.00 income · posted Jan 12, 2026

Lobbying activity 1

Pharmacy

Prescription drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem